Company News Release
SGS Leverages Phase Forward's InForm and Central Designer Solutions for Greater Clinical Trial Efficiencies
Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
Phase Ia, open-label, escalating dose study to evaluate the safety and immunogenicity of therapeutic vaccine, TherVacB.
Bringing the Clinical Trials Industry Together
Micah Lieberman, Executive Director, Conferences (CHI) & Co-Founder, VP, Community and Business Development (ClinEco) discusses what ClinEco is and what attendees can expect at SCOPE.
FDA Issues Cautionary Reminder to Medical Device Manufacturers Regarding Data Submitted from Third-Party Laboratories
Agency reports concerns amid an increase in submitted data that has been fabricated, duplicated, or unreliable from third-party laboratories.
Managing Digital Studies in the Current Landscape
Flo Mowlem, VP of Science at ObvioHealth discusses digital study design—touching on how to best manage data and medical devices.
A Cross-Sectional Study of Patient Perspectives on Clinical Trial Participation in a Large Community-Based Research Facility
An overview of patient perceptions of cancer clinical trials and the consent process among those who are currently enrolled in, or who recently completed, a cancer clinical trial.
How AI is Changing Early Drug Development
Though artificial intelligence has yet to achieve its full potential, meaningful strides are still being made across the drug discovery funnel.
2 Commerce Drive Cranbury, NJ 08512